Generalised anxiety disorder Treatment

Psychological therapies for anxiety

Psychotherapy, also known as talk therapy or psychological counseling, is one of the most effective treatments for generalised anxiety disorder. It involves working with a trained therapist to understand and manage anxiety symptoms. The most researched and effective form of psychotherapy for GAD is cognitive behavioral therapy, or CBT for short.2

Cognitive behavioral therapy has two main components. The cognitive part focuses on identifying and changing thought patterns that trigger or worsen anxiety. People with GAD often perceive situations as threatening even when they aren't, and CBT helps them recognize these distorted thoughts. The behavioral part involves gradually facing feared situations rather than avoiding them. Through repeated exposure to anxiety-provoking scenarios in a controlled way, people learn that their feared outcomes rarely happen, and their anxiety naturally decreases over time.4

CBT is typically offered as weekly sessions over several weeks or months. In some cases, these sessions can be conducted virtually through video calls, making treatment more accessible. The therapy teaches specific skills that people can use to directly manage their worries. As patients practice these techniques and see improvement, they gradually return to activities they had been avoiding because of anxiety. The benefits of CBT extend beyond just reducing anxiety—it can also help with symptoms of depression, which often accompany GAD.4

It's worth noting that CBT involves directly confronting fears, which can be distressing during the therapy process itself. Some people find the exercises challenging or uncomfortable at first. However, therapists guide patients through this process carefully, starting with less anxiety-provoking situations and building up gradually.4

Medications recommended for generalised anxiety disorder

Several types of medications have been proven effective in treating GAD. The most commonly prescribed are antidepressants, particularly two classes: selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). These medications are recommended as first-line treatment by clinical guidelines.3

SSRIs and SNRIs work by affecting chemical messengers in the brain called neurotransmitters, specifically serotonin and norepinephrine. These chemicals play important roles in regulating mood and anxiety. When someone has GAD, there may be imbalances in how these neurotransmitters function. The medications help restore more normal levels and improve the brain's ability to manage stress and worry.5

It's important to understand that these medications don't work immediately. Most people need to take them for several weeks before they notice significant improvement in their anxiety symptoms. Once symptoms improve, doctors typically recommend continuing the medication for at least six to twelve months to reduce the risk of symptoms returning. Stopping medication too soon is a common reason for relapse.3

Like all medications, antidepressants can cause side effects. Common ones include nausea, changes in appetite or weight, sleep disturbances, and sexual problems. Most side effects are mild and improve over time as the body adjusts to the medication. However, some people may need to try different medications to find one that works well with minimal side effects.2

Combining treatments for better results

Many people benefit most from a combination of psychotherapy and medication. Research shows that both approaches can be effective on their own, but using them together often produces better outcomes than either treatment alone. The medication can help reduce symptoms enough that the person can engage more effectively in therapy, while therapy provides skills and strategies that continue to help even after medication is stopped.2

Healthcare providers usually recommend trying talking therapies before prescribing medication, or alongside it from the beginning. The choice depends on the severity of symptoms, the person's preferences, and whether they've tried treatments before. Some people prefer to avoid medication if possible, while others find that medication gives them the stability they need to participate in therapy.6

When standard treatments don't work well enough

Around half of the people treated for generalised anxiety disorder don't respond adequately to their first treatment attempt. When someone has tried at least one antidepressant at an appropriate dose for an appropriate length of time and still has significant symptoms, doctors describe this as treatment-resistant GAD. This situation is more common than many people realize, and it has led researchers to investigate alternative medication approaches and strategies to augment standard treatments.7

Treatment-resistant doesn't mean untreatable. It simply means that additional or different strategies need to be explored. In these situations, doctors might try switching to a different medication, adding a second medication to boost the effects of the first, or combining medication with more intensive psychotherapy.7

Medications affecting brain chemistry in new ways

Research into treatment-resistant GAD has identified several medication classes that show promise when added to standard antidepressants. One class that has generated considerable research interest is the GABA-related agents. GABA, which stands for gamma-aminobutyric acid, is a neurotransmitter that helps calm brain activity. People with anxiety disorders may have abnormalities in their GABA system.7

Pregabalin is a medication that affects GABA activity in the brain. Originally developed for treating nerve pain and seizures, researchers found that it also reduces anxiety symptoms. Clinical trials have tested pregabalin as an additional treatment for people whose anxiety hasn't responded well to standard antidepressants. The medication appears to work relatively quickly, sometimes within a week or two, which is faster than typical antidepressants.7

Another GABA-related medication studied in clinical trials is tiagabine, which increases GABA levels in the brain by preventing its breakdown. Early phase studies examined whether tiagabine could help reduce anxiety when added to existing treatments. However, research on this medication for anxiety is more limited compared to pregabalin.7

Side effects of GABA-related medications can include dizziness, drowsiness, weight gain, and coordination problems. Researchers in clinical trials carefully monitor participants for these and other potential side effects to determine whether the benefits outweigh the risks.7

Atypical antipsychotics as augmentation therapy

Atypical antipsychotics are another class of medications being investigated for treatment-resistant generalised anxiety disorder. These medications were originally developed to treat conditions like schizophrenia and bipolar disorder, but researchers have found that at lower doses, some of them might help reduce anxiety symptoms when standard treatments aren't working well enough.7

These medications work by affecting multiple neurotransmitter systems in the brain, including dopamine and serotonin. The theory is that by modulating these chemical messengers in different ways than standard antidepressants, atypical antipsychotics might help people whose brain chemistry doesn't respond well to SSRIs or SNRIs alone. Clinical trials have tested several medications in this class as add-on treatments to ongoing antidepressant therapy.7

The use of atypical antipsychotics for anxiety remains somewhat controversial because these medications can have significant side effects. These can include weight gain, metabolic changes affecting blood sugar and cholesterol, drowsiness, and movement problems. For this reason, they are typically considered only when other treatment options have been tried and found insufficient. Clinical trials carefully track both the benefits and potential harms to help determine which patients might benefit most from this approach.7

Understanding what clinical trials measure

When researchers test potential treatments for GAD in clinical trials, they measure several things to determine whether a treatment is working. They track changes in symptom severity using standardized questionnaires that ask about worry, physical symptoms, and how much anxiety interferes with daily life. They also monitor side effects carefully, asking participants regularly about any new symptoms or problems they're experiencing.7

Many clinical trials are conducted at major medical centers and universities, though some take place in community clinics as well. Trials may be specific to certain countries or regions, or they may be international studies. People interested in participating typically need to meet specific criteria—for example, having tried at least one standard treatment without adequate improvement, being within a certain age range, and not having certain other medical conditions that could interfere with the study.7

Preliminary results from clinical trials can provide hope, but it's important to remember that not all promising early findings lead to approved treatments. A medication might show benefits in early trials but later prove to have unacceptable side effects or work no better than existing treatments when studied more thoroughly. The clinical trial process is designed to protect patients by carefully vetting new treatments before they become widely available.7